1. Campbell, P.M., Leroy, R.C. Pathogenesis of systemic sclerosis; A vascular hypothesis. Semin Arthritis Rheum 1975, 4, 351–68.
2. Medsger, T.A.Jr. Systemic sclerosis (scleroderma), eosinophilic fasciitis, and calcinosis. In: Arthritis and Allied Conditions, 10th ed. Editor: Mc Carthy, D.J.: Philadelphia, Lea & Febiger, 1985, 994–1036.
3. Currie, S., Saunders, M., Knowles, N. Immunological aspects of systemic sclerosis; in vitro activity of lymphocytes of patients with the disorder. Br J Dermatol 1971, 84, 400–9.
4. Catoggio, L.J., Bernstein, R.M., Black, C.M., Hughes, G.R.V., Maddison, P.J. Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis 1983, 42, 23–7.
5. Kallenberg, C.G.M., Van der Vobrt-Beelen, J.M., D'Amarp, J., The T.H. Scleroderma, increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol 1981, 43, 478–85.